Overview
Study of AK156 in Primary Osteoporosis Patients
Status:
Completed
Completed
Trial end date:
2015-01-01
2015-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to investigate the efficacy and safety of AK156 in Japanese patients with primary osteoporosis.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Asahi Kasei Pharma Corporation
Criteria
Inclusion Criteria:- Patients diagnosed with primary osteoporosis
- Patients who have vertebral fractures at the time of screening
Exclusion Criteria:
- Patients diagnosed with secondary osteoporosis
- Patients with a current uncontrolled medical disorder or other condition which makes
the patient unsuitable for the study